Literature DB >> 7625113

Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia.

S Chhibber1, J Bajaj.   

Abstract

Klebsiella pneumoniae has become an important cause of both community-acquired and nosocomial infections. In this study an attempt was made to study the immunogenicity of iron-regulated cell surface proteins (IRCSP) alone or in conjunction with the polysaccharide moiety of lipopolysaccharide (LPS) of K. pneumoniae. The polysaccharide-iron-regulated cell surface protein conjugate (PS-IRCSP) was non-toxic and non-pyrogenic. It was found to be immunogenic and the protection afforded by the conjugate against the challenge strain was observed in a rat lobar pneumonia model. The protection observed with the conjugate was higher than that observed with polysaccharide or IRCSP alone. The conjugate elicited both agglutinating and bactericidal antibodies. Enhanced phagocytosis was observed for the alveolar macrophages obtained from the lungs of animals treated with conjugate compared with macrophages obtained from animals treated with other antigenic preparations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625113     DOI: 10.1016/0264-410x(95)93133-t

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae.

Authors:  U C Chathley; S Sharma; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

2.  Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.

Authors:  Prathiba Kurupati; N P Ramachandran; Chit Laa Poh
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.

Authors:  Urban Lundberg; Beatrice M Senn; Wolfgang Schüler; Andreas Meinke; Markus Hanner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

5.  Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries.

Authors:  Loretta Brabin; Bernard J Brabin; Sabine Gies
Journal:  Nutr Rev       Date:  2013-06-06       Impact factor: 7.110

6.  Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.

Authors:  Melha Mellata; Natalie M Mitchell; Florian Schödel; Roy Curtiss; Gerald B Pier
Journal:  Vaccine       Date:  2015-12-18       Impact factor: 3.641

7.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

Review 8.  Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae.

Authors:  Tarek A Ahmad; Medhat Haroun; Ahmad A Hussein; El Sayed H El Ashry; Laila H El-Sayed
Journal:  Infect Dis Rep       Date:  2012-07-23

9.  Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model.

Authors:  Litty Babu; Siva R Uppalapati; Murali H Sripathy; Prakash N Reddy
Journal:  Front Microbiol       Date:  2017-09-20       Impact factor: 5.640

10.  Fighting Antibiotic-Resistant Klebsiella pneumoniae with "Sweet" Immune Targets.

Authors:  Roberto Adamo; Immaculada Margarit
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.